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jou rn al hom ep age: ht tp : / /www.e lsev ier .com/ locate / rpor
ditorialhe next  generation  of  medical  physicistsn May 2013, a group of four students studying Medical Physics
t the University of Warsaw, together with the help of several
ecturers from various Polish Universities, organized a confer-
nce entitled “The Warsaw Medical Physics Meeting”. Nearly
0 young physicists participated in the event and several inter-
sting presentations were given by the young physicists and
heir professors.
After the conference, a proposal was made to publish the
est of these lectures in Reports of Practical Oncology and
adiotherapy. The result is this supplement of RPOR, which
ou are reading right now. For most of these promising young
hysicists, this is the ﬁrst paper they have ever published.
s anyone who has ever spent time preparing and writ-
ng a manuscript knows, the process of writing a paper is
ore complex than it might at ﬁrst appear. For this reason,
hese students were given expert guidance by their tutors. We
elieve that readers will agree with us when we commend the
uthors for the excellent results of their hard work.
The work of medical physicists typically involves the appli-
ation of ionizing radiation in medicine and in that respect, all
apers published in this supplement address aspects related
o the medical application of ionizing radiation. What follows
s a brief introduction to the papers included in this supple-
ent.
Proton therapy is becoming increasingly important as new
roton therapy centers open around the world each year.
he ﬁrst proton therapy center for deep tumors will open in
rakow next year (2015). In this sense, the paper written by
nna Dawidowska1 is timely. In her paper, Ms.  Dawidowska
escribes the problem of energy deposition due to the (p,n)
eaction during proton therapy. Proton therapy is an emerg-
ng ﬁeld within radiotherapy and it is important that young
esearchers develop expertise in this area. This paper is an
xcellent contribution to the ﬁeld.
In our present era of Intensity Modulated Radiotherapy
IMRT), only very sophisticated methods of dose optimization
re of interest, and this is as it should be. However, Marta
rystyna Giz˙yn´ska and Paweł Kukołowicz2 have written a
ell-developed article that provides a good overview of issuesrelated to dose distribution optimization and we  believe that
this paper could be valuable educational material for lecturers
in the ﬁeld of radiotherapy.
Readers will also ﬁnd two papers related to nuclear
medicine. In the ﬁrst paper,3 Krzysztof Kilian describes the
current status and future perspectives of 68a-DOTA and
analogs. This topic is relevant to all involved in nuclear
medicine. The same author has also written a second arti-
cle regarding the quality control process in the synthesis
of 18F-Fludeoxyglucose.4 In that article, Kilian et al. share
their experience in the quality control process to ensure that
metallic impurities are reduced to an acceptable level. Quality
control is one of the most important everyday tasks performed
by medical physicists, and for this reason this article will inter-
est all medical physicists, not just those who  work in the ﬁeld
of nuclear medicine.
An important task of medical physicists is to accurately and
reliably measure the radiation energy deposited in tissues. In
radiotherapy, it is essential to be sure that the intended dose is
delivered as expected. This process is checked by using beam
monitor detectors. In an interesting paper included here, Kon-
rad Nesteruk5 describes three new beam monitor detectors for
ionizing radiation. These detectors can be used with various
types of beams and for both hadrontherapy and radioisotope
production.
Physicists are often involved in radiobiological research,
especially given its relevance to medical radiotherapy. One
important and highly relevant radiobiological phenomenon
is the bystander effect. This effect is still incompletely
understood, although several articles published in this jour-
nal have addressed this topic.6,7 In fact, in an upcoming
issue of RPOR, a review article will address this topic in
depth. Conﬂicting reports have been published regarding
whether or not irradiated cells inﬂuence surrounding cells.
In 1992, this phenomenon was described by Nagasawa and
Little,8 although the underlying mechanisms for the bystander
effect are still not fully elucidated. Interestingly, Urszula
Kaz´mierczak et al.9 investigated this effect in Chinese ham-
ster ovary cells (CHO-K1) irradiated with high LET 12C ions
nd ra
r
1
http://dx.doi.org/10.1016/j.rpor.2014.04.010S2  reports of practical oncology a
and X-rays at the dose range of 0.1–4 Gy. As the authors report,
no bystander effect was observed. Clearly, more  studies will
be needed before any deﬁnitive conclusions can be made
regarding the bystander effect.
Finally, Marcin Pietrzak et al. have written a very interest-
ing article entitled “Status report: nanodosimetry of carbon ion
beams at HIL”.10 Nanodosimetry is an emerging area of radio-
physics which seeks to measure DNA damage to nanometric
target volumes. Readers who are unfamiliar with this topic
will ﬁnd this article to be an excellent overview of the ﬁeld,
particularly as practiced at the Heavy Ion Laboratory (HIL) in
Warsaw, Poland.
In conclusion, I believe that readers will be pleasantly sur-
prised by the quality and relevance of the articles in this
supplement. Enjoy!
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